Clinical trial
A Randomized, Double-Blind, Controlled Study of the Safety and Performance of…
NCT00299026 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00299026 |
|---|---|
| Title | A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent |
| Official title | TAXUS II: A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | NIRx(TM) Paclitaxel-Coated Conformer Coronary Stent System |
| Enrollment | 532 |
| Start date | Jun 1, 2001 |
| Primary completion | May 1, 2003 |
| Completion | Feb 1, 2007 |
| First posted | Mar 6, 2006 |
| Last update posted | Mar 3, 2017 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: